Assessment of amino-terminal C-type natriuretic peptide serum level and its correlation with high-density lipoprotein structure and function in patients with end stage renal disease before and after kidney transplantation.


Journal

Chemico-biological interactions
ISSN: 1872-7786
Titre abrégé: Chem Biol Interact
Pays: Ireland
ID NLM: 0227276

Informations de publication

Date de publication:
01 Nov 2023
Historique:
received: 14 07 2023
revised: 28 09 2023
accepted: 04 10 2023
medline: 1 11 2023
pubmed: 7 10 2023
entrez: 6 10 2023
Statut: ppublish

Résumé

We aimed to investigate serum amino-terminal C-type natriuretic peptide (NT-proCNP) and its relationship with quantitative and qualitative HDL-parameters in patients with end-stage renal disease (ESRD) before, then 1 and 6 months after kidney transplantation (TX). Seventy patients (47 males, 23 females, mean age 51.7 ± 12.4 years) were enrolled in a prospective follow-up study. We examined serum creatinine, C-reactive protein, procalcitonin, fasting glucose and lipid parameters before, then 1 and 6 months after TX. High-density lipoprotein- (HDL)-associated paraoxonase-1 (PON1) paraoxonase and arylesterase activities were measured spectrophotometrically. Lipoprotein subfractions were determined by Lipoprint. NT-proCNP and oxidized low-density lipoprotein (oxLDL) levels were measured by ELISA. Mean NT-proCNP was 45.8 ± 21.9 pmol/L before renal transplantation and decreased markedly 1 month and 6 months after transplantation (5.3 ± 2.5 and 7.7 ± 4.9 pmol/L, respectively, P = 1 × 10

Identifiants

pubmed: 37802408
pii: S0009-2797(23)00416-7
doi: 10.1016/j.cbi.2023.110749
pii:
doi:

Substances chimiques

Natriuretic Peptide, C-Type 127869-51-6
Lipoproteins, HDL 0
Procalcitonin 0
Aryldialkylphosphatase EC 3.1.8.1
Creatinine AYI8EX34EU
Vasodilator Agents 0
Cholesterol 97C5T2UQ7J
PON1 protein, human EC 3.1.8.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110749

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Réka Szentimrei (R)

Division of Metabolic Diseases, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary; Doctoral School of Health Sciences, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. Electronic address: szentimrei@belklinika.com.

Hajnalka Lőrincz (H)

Division of Metabolic Diseases, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. Electronic address: lorincz_hajnalka@belklinika.com.

Anita Szentpéteri (A)

Division of Metabolic Diseases, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. Electronic address: szentpeteri.anita@gmail.com.

Viktória Evelin Varga (VE)

Division of Metabolic Diseases, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. Electronic address: vargavikievelin@gmail.com.

Ildikó Seres (I)

Division of Metabolic Diseases, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. Electronic address: seres@belklinika.com.

Éva Varga (É)

Department of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary. Electronic address: varga.eva@med.semmelweis-univ.hu.

Balázs Nemes (B)

Institute of Surgery, Department of Organ Transplantation, University of Debrecen, Debrecen, Hungary. Electronic address: nemes.balazs@med.unideb.hu.

Mariann Harangi (M)

Division of Metabolic Diseases, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. Electronic address: harangi@belklinika.com.

György Paragh (G)

Division of Metabolic Diseases, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. Electronic address: paragh@belklinika.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH